Former India cricketer Yuvraj Singh's foray into the health and wellness sector with his new supplement brand, Protocol32, has ignited a significant controversy. Prominent medical professionals have voiced strong concerns, challenging the scientific backing and safety of the multi-ingredient product.
Doctors Question Protocol32's Scientific Claims
The criticism stems notably from Dr. Cyriac Abby Philips, widely known as 'The Liver Doc,' a hepatologist and clinician-scientist, and Dr. C.S. Pramesh, Director of Tata Memorial Hospital in Mumbai. Both doctors have publicly questioned the evidence supporting Protocol32's health claims and cautioned Yuvraj Singh against leveraging his considerable celebrity influence to promote supplements without robust scientific validation.
Yuvraj Singh introduced Protocol32 by linking it to his personal health journey, including his battle with cancer during the 2011 Cricket World Cup. He described the product as a daily sachet combining 32 FSSAI-approved supplements, designed to support various biological functions, including energy, brain health, sleep, immunity, and liver health. Key ingredients listed include creatine, magnesium, vitamins C, D3, E, B12, zinc, folic acid, and herbal extracts like ashwagandha, bacopa, curcumin, and boswellia.
Concerns Over Multi-Ingredient Blends and Liver Health
Dr. Philips's critique focused on several aspects. He accused Yuvraj of promoting a product without fully understanding its scientific basis, emphasizing the responsibility of celebrities to advocate for evidence-based healthcare. A primary concern raised by Dr. Philips is the combination of multiple herbal ingredients, specifically ashwagandha, bacopa, curcumin, and boswellia, which he noted have been implicated in cases of liver injury. He also questioned the dosages of certain ingredients within Protocol32, suggesting they might be too low to deliver clinically demonstrated benefits.
Furthermore, Dr. Philips highlighted that the presence of numerous ingredients does not guarantee their combined effectiveness or safety. He challenged the claims that Protocol32 supports multiple biological pathways simultaneously, demanding robust human clinical trials to substantiate such assertions. Dr. Pramesh echoed these sentiments, expressing disappointment and urging Yuvraj to be more judicious in using his public platform, asking for evidence to support the product's claims and warning against allowing financial incentives to mislead followers.
FSSAI Approval vs. Scientific Efficacy
The controversy also reignites a broader debate regarding the safety of multi-ingredient supplements, the efficacy of herbal formulations, and the rapidly expanding preventive healthcare market. An important distinction highlighted is that compliance with regulatory bodies like the Food Safety and Standards Authority of India (FSSAI) should not be conflated with scientific proof of health benefits. While FSSAI regulates ingredients, composition, and labeling for safety, its approval does not automatically validate all marketing claims or guarantee the efficacy of complex formulations combining dozens of ingredients.
Experts stress that while dietary supplements can address specific nutritional deficiencies, their benefits depend heavily on the ingredients, dosage, individual nutritional needs, and potential interactions with other medications. The safety of any multi-ingredient formulation must be assessed based on the complete product, rather than assuming that evidence for individual components applies to their combination. As the debate continues, both consumers and industry stakeholders are urged to prioritize evidence-based information and transparency in health product endorsements.